1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
CAS : 77181-69-2
Ref. AN-AG003AJW
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
Nom :
1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
Synonymes :
- [u'1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil', u'1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil', u'5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil', u'brovavir', u'BV-ara-U', u'BV-araU', u'sorivudine', u'SORIVUDINE', u'Bravavir', u'Usevir', u'Brovavir', u'77181-69-2', u'BVAU', u'BV-Ara-U', u'YN-72', u'Bromovinyluridine', u'5-Bromovinyl-araU', u'BV-araU', u'Sorivudinum [INN-Latin]', u'SQ-32756', u'Sorivudina [INN-Spanish]', u'UNII-C7VOZ162LV', u'ARYS-01', u'CCRIS 5285', u'(E)-5-(2-Bromovinyl)uridine', u'DRU-0136', u'C7VOZ162LV', u'(E)-5-(2-Bromovinyl)-1-beta-D-arabinofuranosyluracil', u'CHEMBL70046', u'1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil', u'(+)-1-beta-D-Arabinofuranosyl-5-((E)-2-bromovinyl)uracil', u'(E)-1-beta-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione', u'1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil', u'Sorivudina', u'Sorivudinum', u'2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)-, (E)-', u'C11H13BrN2O6', u'Bromovinyl araU', u'BVaraU', u'Sorivudine [USAN:BAN:INN:JAN]', u'Sorivudine [USAN:INN:BAN:JAN]', u'Bravavir (TN)', u'BV ara-U', u'AC1NQZN1', u'SCHEMBL82640', u'Sorivudine (JAN/USAN/INN)', u'CHEBI:32152', u'5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione', u'ZINC3653374', u'BDBM50206491', u'JA-001', u'AKOS025149268', u'DB11998', u'SB18958', u'SO-32756', u'LS-135099', u'SQ 32,756', u'D01734', u'5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil', u'1-.beta.-D-arabinofuranosyl-5-(2-bromovinyl)uracil', u'1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil', u'2,4(1H,3H)-Pyrimidinedione, 1-.beta.-D-arabinofuranosyl-5-[(1E)-2-bromoethenyl]-', u'5-((E)-2-Bromo-vinyl)-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-4-hydroxy-1H-pyrimidin-2-one', u'5-[(E)-2-bromovinyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione', u'Usevir (TN)', u'D03TGJ', u'C11-H13-Br-N2-O6', u'CID5282192', u'1-beta-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione']
- (+)-1-beta-D-Arabinofuranosyl-5-((E)-2-bromovinyl)uracil
- (E)-1-beta-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione
- (E)-5-(2-Bromovinyl)-1-(β-<span class="text-smallcaps">D</span>-arabinofuranosyl)uracil
- (E)-5-(2-Bromovinyl)-1-beta-D-arabinofuranosyluracil
- (E)-5-(2-Bromovinyl)uridine
- 1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil
- 1-beta-D-arabinofuranosyl-5-[(E)-2-bromoethenyl]pyrimidine-2,4(1H,3H)-dione
- 1-β-<span class="text-smallcaps">D</span>-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil
- 1-β-<span class="text-smallcaps">D</span>-Arabinofuranosyl-5-(2-bromovinyl)uracil
- Voir d'autres synonymes
- 1-β-<span class="text-smallcaps">D</span>-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
- 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)-, (E)-
- 2,4(1H,3H)-Pyrimidinedione, 1-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-5-(2-bromoethenyl)-, (E)-
- 2,4(1H,3H)-Pyrimidinedione, 1-β-<span class="text-smallcaps">D</span>-arabinofuranosyl-5-[(1E)-2-bromoethenyl]-
- 5-Bromovinyl-araU
- Arabinosyl (E)-5-(2-bromovinyl)uracil
- BV-Ara-U
- BVaraU
- Bravavir
- Bromovinyluridine
- Brovavir
- Ccris 5285
- Dru-0136
- Sorivudina
- Sorivudina [INN-Spanish]
- Sorivudine [USAN:INN:BAN:JAN]
- Sorivudinum
- Sorivudinum [INN-Latin]
- Sq-32756
- Usevir
- Yn-72
CAS :
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
349.1347
Formule :
C11H13BrN2O6
Degré de pureté :
95%
Couleur/Forme :
Solid
InChI :
InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1
Code InChI :
GCQYYIHYQMVWLT-HQNLTJAPSA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :